Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study (Q34118216)

31 July 2017

Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study (English)

1 reference

31 July 2017

5

Albert Hofman

1 reference

31 July 2017

7

Monique M B Breteler

1 reference

31 July 2017

Sarah E Vermeer

1

1 reference

31 July 2017

Ewoud J van Dijk

2

1 reference

31 July 2017

Peter J Koudstaal

3

1 reference

31 July 2017

Matthijs Oudkerk

4

1 reference

31 July 2017

Robert Clarke

6

1 reference

31 July 2017

1 March 2002

1 reference

31 July 2017

1 reference

31 July 2017

51

1 reference

31 July 2017

3

1 reference

31 July 2017

285-289

1 reference

Subcortical silent brain infarction as a risk factor for clinical stroke.

31 July 2017

1 reference

Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

21 January 2018

1 reference

White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging

21 January 2018

1 reference

Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study

21 January 2018

1 reference

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.

21 January 2018

1 reference

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

21 January 2018

1 reference

Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution.

21 January 2018

1 reference

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

21 January 2018

1 reference

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

Identification of cognitive impairment in the elderly: homocysteine is an early marker.

21 January 2018

1 reference

Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people

21 January 2018

1 reference

Homocysteine and cardiovascular disease

21 January 2018

1 reference

Determinants of disease and disability in the elderly: The Rotterdam elderly study

21 January 2018

1 reference

Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

21 January 2018

1 reference

Cerebral white matter lesions and atherosclerosis in the Rotterdam Study

21 January 2018

1 reference

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

Pathogenesis of leukoaraiosis: a review

21 January 2018

1 reference

Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces.

21 January 2018

1 reference

Homocysteine and vascular disease

21 January 2018

1 reference

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10111

1 reference

31 July 2017

1 reference